New Immunotherapy for Deadly Childhood Brain Cancer Targets Novel 'Neoantigen'

Children with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutant form of a protein found exclusively on cancer cells, according to a new study led by UC San Francisco researchers.

Read more: https://www.ucsf.edu/news/2017/12/409196/new-immunotherapy-deadly-childhood-brain-cancer-targets-novel-neoantigen